In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors

Human Gene Therapy

Volumn 12, Issue 8, 2001, Pages 871-881

  Pieroni, L ^a,b   Maione, D ^a   La Monica, N ^a  

^a IRBM   (Italy)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; ERYTHROPOIETIN; POLYHEDRIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACULOVIRUS; COMPLEMENT SYSTEM; CONTROLLED STUDY; CYTOMEGALOVIRUS; ESCHERICHIA COLI; FEMALE; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MAMMAL CELL; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; VESICULAR STOMATITIS VIRUS; VIRUS ENVELOPE; VIRUS INACTIVATION;

ANIMALS; BACULOVIRIDAE; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CELL LINE; DNA, COMPLEMENTARY; ENHANCER ELEMENTS (GENETICS); ERYTHROPOIETIN; ESCHERICHIA COLI; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUSCLE, SKELETAL; MUSCLE, SMOOTH; PROMOTER REGIONS (GENETICS); SPECIES SPECIFICITY; TIME FACTORS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS;

ANIMALIA; BACTERIA (MICROORGANISMS); CYTOMEGALOVIRUS; DNA VIRUSES; ESCHERICHIA COLI; MAMMALIA; UNIDENTIFIED BACULOVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0034920468     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401750195845     Document Type: Article

References (40)

1. Human gene therapy
2. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein
3. Molecular medicine: Muscle-based gene therapy
4. Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector
5. Baculovirus mediated gene transfer into mammalian cells
6. The use of adenoviral vectors for gene therapy and gene transfer in vivo
7. Transient and stable gene expression in mammalian cells transduced by a recombinant baculovirus vector
8. Erythropoietin gene transfer and expression in adult normal mice: Use of an adenovirus vector
9. Expression of hepatitis C virus cDNA in human hepatoma cell line mediated by a hybrid baculovirus-HCV vector
10. Recombinant adeno-associated virus for muscle directed gene therapy
11. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system
12. Efficient gene transfer into human hepatocytes by baculovirus vectors
13. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
14. Are contemporary methods for somatic gene therapy suitable for clinical applications?
15. Liposome-induced activation of the classical complement pathway does not require immunoglobulin
16. Adenovirus-mediated gene transfer: Influence of transgene, mouse strain, and type of immune response on persistence of transgene expression
17. Human gene therapy comes of age
18. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector
19. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors
20. Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery
21. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle
22. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation
23. Gene electrotransfer results in high-level transduction of rat skeletal muscle and corrects anemia of renal failure
24. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors
25. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice
26. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors
27. Viral vectors in gene therapy
28. Efficient and stable adeno-associated virus mediated transduction in skeletal muscle
29. Muscle-based gene therapy: Realistic possibilities for the future
30. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector
31. Sensitization of cells and retroviruses to human serum by (α1-3) galactosyltransferase
32. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus
33. Slp is an essential component of an EDTA-resistant activation pathway of mouse complement
34. Muscle maturation: Implications for gene therapy
35. Gene therapy - Promises, problems and prospects
36. Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle
37. Human serum lyses RNA tumor viruses
38. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vectors
39. A hybrid baculovirus-T7 RNA polymerase system for recovery of an infectious virus from cDNA